BDMD (Baird Medical Corp) Company Projected Revenue

Brandmark of bairdmed.com (BDMD)

Baird Medical Investment develops microwave ablation systems, maintaining high margins through the control of electronics supplies. The company's target sales level demonstrates demand dynamics, where 0.02 represents the current metric level. Revenues are based on the regular sale of disposable needles, while the optimization of transport routes from Asia to Europe and the US minimizes logistical risks.

BDMD - Baird Medical Investment Company Expected Sales Volume over the range 10/03/2024 - 11/18/2026

Analytical breakdowns and data insights for company Baird Medical Investment (BDMD)

Fundamental company analysis:Baird Medical Investment Holdings
Brand item of Baird Medical Corp

Future sales volume determines the permissible threshold for revenue decline until the data is officially reflected in financial statements. Investors utilize this threshold for risk control and to protect capital from sudden drawdowns. By analyzing changes in future sales volume, one can assess the sustainability of the microwave ablation systems expansion led by Haiyan Li at Baird Medical Investment (BDMD). This metric confirms the company's financial stability during its entry into the US market, allowing for a balance between conservative asset protection and growth potential.

Analysis of competing companies

Company Future Sales Volume DXCM (Dexcom)|Company Future Sales Volume Penumbra PEN|Company Projected Revenue Novanta Photonics NOVT|Haemonetics Corp. (HAE) - Company Expected Sales Volume|Inspire Medical - Projected Sales Volume|Company Expected Sales Volume PROCEPT BioRobotics|CNMD: Projected Sales Volume|Company Revenue Forecast PLSE|INMD (InMode MD) - Projected Sales Volume|Company Future Sales Volume Picard Medical Inc. (PMI)|Projected Sales Volume SRDX|Company Future Sales Volume Senseonics Holdings SENS|Projected Sales Volume NPCE (neuropace.com)|Projected Sales Volume Tactile Systems Technology TCMD|SNWV - Company Projected Revenue|Company Expected Sales Volume Outset Medical Corp|ELMD (Electromed Inc) - Company Future Sales Volume|LENSAR, Inc. - Company Future Revenue|RCEL (AVITA Medical Inc) - Projected Sales Volume|Company Expected Sales Volume profoundmedical.com PROF|Company Projected Revenue EDAP TMS (EDAP)|Bovie Medical (APYX) - Company Sales Forecast|IceCure Medical Ltd. - Company Future Sales Volume|Projected Sales Volume Pulmonx Corp. LUNG|TELA Bio Inc. - Projected Sales Volume|Company Future Sales CytoSorbents Corporation CTSO|Sensus Healthcare (SRTS) - Company Projected Revenue|Company Expected Revenue ZYXI (Zynex Corp)|Company Projected Revenue electrocore.com|Company Future Sales Volume Vicarious Surgical Inc. (RBOT)|Projected Sales Volume IINN|SeaStar Medical Holding Corp - Company Revenue Forecast|Company Projected Revenue iridex.com IRIX|INBS: Company Revenue Forecast|XAIR: Company Future Sales Volume|profusa.com - Company Projected Revenue Volume|STRATA Skin Sciences (SSKN) - Company Projected Revenue|Company Sales Forecast glucotrack.com GCTK|NAOV (nanovibronix.com) - Projected Sales Volume|Company Expected Sales Volume Venus Concept Corporation VERO|Company Future Sales Volume NUWE (nuwellis.com)|Company Projected Revenue Volume AEMD|Company Projected Revenue asensus.com ASXC|AVGR: Company Revenue Forecast|BioSig Technologies, Inc - Projected Sales Volume|Company Future Revenue CUTR (Cutera, Inc)|KNW: Projected Sales Volume|inarimedical.com - Company Future Revenue|NVRO (Nevro Corp) - Projected Sales Volume|Company Expected Sales Volume ReShape Lifesciences Inc. RSLS|Projected Sales Volume SILK